Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


Pharmaceutical Flow Cytometry & Imaging Show

10 Oct 2012 - 11 Oct 2012 - AstraZeneca Conference Centre, AstraZeneca R&D Alderley Park, UK



Bookmark and Share


Following on from the great success and positive feedback from our previous meetings, we are continuing to include topics of current interest by adding Phenotypic Screening and Personalised Health Care to the areas that will be addressed.  Typical attendees will be colleagues from small-to mid-sized biotech companies, contract research organisations and global pharmaceutical companies. The content of this free two day meeting will also include other industrial-based themes covering the drug development journey from discovery to clinical evaluation.

Topics over two days will include:

Lead Generation - high throughput / high content screening
Pharmaceuticals - monoclonal antibodies and fragments 
Drug attrition - safety and secondary pharmacology
Stem cells - range of application in discovery research and therapy
Biomarkers - method validation, clinical study support & outsourcing of cell-based assays
New techniques and applications - novel agents, instruments and analysis
Phenotypic Screening - complex and cell based assays
Personalised Health Care - decision making biomarkers, companion diagnostics & life-cycle management

Posters - Submit an Abstract to:  posters@elrig.org
Exhibition Trade Show - Book your stand at www.elrig.org
2 Days Scientific Sessions - Leaders in Flow and Imaging will be presenting

Register and Attend FREE OF CHARGE go to: www.elrig.org


Further information
Scientific News
New Autism Blood Biomarker Identified
Researchers at UT Southwestern Medical Center have identified a blood biomarker that may aid in earlier diagnosis of children with autism spectrum disorder, or ASD.
It’s Now Easier To Go With The Flow
Rice University tool simplifies comparison of flow cytometry data for laboratories.
FNIH Launches Project to Evaluate Biomarkers in Cancer Patients
Company has announced that it has launched a new project to evaluate the effectiveness of liquid biopsies as biomarkers in colorectal cancer patients.
Drugs that May Combat Deadly Antibiotic-Resistant Bacteria Uncovered
Study identifies 79 compounds that inhibit carbapenem-resistant Enterobacteriaceae (CRE).
Making Precision Medicine a Reality
Researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and identifying new drug targets and therapies.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!